Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions

American Journal of Transplantation

Volumn 15, Issue 2, 2015, Pages 381-394

  Fontes, P ^a,b   Lopez, R ^a   Van Der Plaats, A ^c   Vodovotz, Y ^a   Minervini, M ^a   Scott, V ^b   Soltys, K ^a   Shiva, S ^d   Paranjpe, S ^a   Sadowsky, D ^a   Barclay, D ^a   Zamora, R ^a   Stolz, D ^a   Demetris, A ^a   Michalopoulos, G ^a   Marsh, J W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Organ Assist   (Netherlands)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

animal models: porcine; basic (laboratory) research science; donors and donation: donation after circulatory death (DCD); ischemia reperfusion injury (IRI); liver transplantation hepatology; metabolomics; organ perfusion and preservation; pathology histopathology; regenerative medicine

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ADENOSINE PHOSPHATE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA INTERFERON; APOLIPOPROTEIN A2; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450; GAMMA INTERFERON; GLYCOCHENODEOXYCHOLIC ACID; HEMOGLOBIN BASED OXYGEN CARRIER; HYPOXANTHINE; LACTIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; METALLOTHIONEIN; OXYGEN; PRESERVATION SOLUTION; PROTEIN FOS; PROTHYMOSIN ALPHA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SYNDECAN 2; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; UREA; HEMOGLOBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE; COLD ISCHEMIA; EXPERIMENTAL PIG; FOLLOW UP; GENERAL MEDICAL DEVICE; GLUCONEOGENESIS; GRAFT SURVIVAL; LIVER BIOPSY; LIVER GRAFT; LIVER PRESERVATION; MACHINE PERFUSION SYSTEM; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION; TRANSCRIPTOMICS; ALLOGRAFT; ANIMAL; COLD; DEVICES; GENE EXPRESSION PROFILING; LIVER; LIVER TRANSPLANTATION; ORGAN PRESERVATION; PERFUSION; PHYSIOLOGY; PIG; PROCEDURES;

ALLOGRAFTS; ANIMALS; COLD TEMPERATURE; GENE EXPRESSION PROFILING; GRAFT SURVIVAL; HEMOGLOBINS; LIVER; LIVER TRANSPLANTATION; METABOLOMICS; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; OXYGEN; PERFUSION; SUS SCROFA;

EID: 84921472605     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12991     Document Type: Article

References (49)

1. Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW., Major challenges limiting liver transplantation in the United States. Am J Transplant 2011; 11: 1773-1784.
2. Orma ES, Barritt S IV, Wheeler SB, Hayashi PH., Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transplant 2013; 19: 59-68.
3. Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death: The University of Wisconsin experience with liver transplantation. Ann Surg 2005; 242: 724-731.
4. Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant-An analysis of the national registry. J Hepatol 2011; 55: 808-813.
5. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: The first clinical series. Am J Transplant 2010; 10: 372-381.
6. Vogel T, Brockmann JG, Coussios CC, Friend PJ., The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury. Transplant Rev 2012; 26: 156-162.
7. Dutkowski P, Schlegel A, de Oliveira M, Müllhaupt B, Clavien PA., HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol 2013; 4: 765-772.
8. van der Plaats A, 't Hart NA, Verkerke GJ, Leuvenink HG, Ploeg RJ, Rakhorst G., Hypothermic machine preservation in liver transplantation revisited: Concepts and criteria in the new millennium. Ann Biomed Eng 2004; 32: 623-631.
9. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG., HBOC-201 as an alternative to blood transfusion: Efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 2008; 64: 1484-1497.
10. Jahr JS, Walker V, Manoochehri K., Blood substitutes as pharmacotherapies in clinical practice. Curr Opin Anesthesiol 2007; 20: 325-330.
11. McNeil JD, Propper B, Walker J, et al. A bovine hemoglobin-based oxygen carrier as a pump prime for cardiopulmonary bypass; reduced system lactic acidosis and improved cerebral oxygen metabolism during low flow in a porcine model. J Thorac Cardiovasc Surg 2011; 142: 411-417.
12. Fontes PA, Marsh JW, Lopez RC, et al. Machine perfusion with a new oxygen-carrier solution: The future of liver preservation [abstract]. Hepatology 2012; 56: 1524A.
13. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 3: 658-663.
14. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D., Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265-1272.
15. Barclay D, Zamora R, Torres A, Namas R, Steed D, Vodovotz Y., A simple, rapid and convenient Luminex TM-compatible method of tissue isolation. J Clin Lab Anal 2008; 22: 278-281.
16. Vekemans K, Balligand E, Liu Q, et al. Differential gene expression profile of porcine livers subjected to warm ischemia alone. Transplant Proc 2011; 43: 3460-3464.
17. Krumsieck J, Suhre K, Evans AM, et al. Mining the unknown: A systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet 2012; 8: e1003005.
18. Mi Q, Constantine G, Ziraldo C, et al. A dynamic view of trauma/hemorrhage-induced inflammation in mice: Principal drivers and networks. PLoS ONE 2011; 6: 19424.
19. Wakelin SJ, Casey J, Robertson A, et al. The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid. Transplant Int 2005; 17: 680-686.
20. Ambiru S, Uryuhara K, Talpe S, et al. Improved survival of orthotopic liver allograft in swine by addition of trophic factors to UW solution. Transplantation 2004; 77: 302-319.
21. Minor T, Koetting M, Koetting M, et al. Hypothermic reconditioning by gaseous oxygen improves survival after liver transplantation in the pig. AJT 2011; 11: 2627-2634.
22. Fondevila C, Hessheimer AJ, Flores E, et al. Step-by-step guide for simplified model of porcine orthtotopic liver transplant. J Surg Res 2011; 167: e39-e45.
23. Huang DW, Sherman BT, Lempicki RA., Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 1: 1-13.
24. Mi H, Muruganujan A, Thomas PD., Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 2013; D1: D377-D386.
25. Nagrath D, Xu H, Tanimura Y, et al. Metabolic preconditioning of donor organs: Defatting fatty livers by normothermic perfusion ex-vivo. Metab Eng 2009; 11: 274-283.
26. Wang H, Harrison-Shostak DC, Wang XF, Nieminen AL, Lemastters JJ, Herman B., Role of phospholipid catabolism in hypoxic and ischemic injury. Adv Lipobiol 1997; 2: 167-194.
27. Namas R, Lagoa C, Barclay D, et al. Hemoadsorption reprograms inflammation in experimental Gram-negative septic peritonitis: Insights from in vivo and in silico studies. Mol Med 2012; 18: 1366-1374.
28. Ueki S, Dhupar R, Cardinal J, et al. Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury. Hepatology 2010; 51: 1692-1701.
29. Kim KH, Dhupar R, Ueki S, et al. Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury. Surgery 2009; 146: 181-189.
30. Weigand K, Brost S, Steinebrunner N, Büchler M, Schemmer P, Müller M., Ischemia/Reperfusion injury in liver surgery and transplantation: Pathophysiology. HPB Surg 2012; doi: 10.1155/2012/176723
31. Abu-Amara M, Yang SY, Tappuria N, Fuller B, Davidson B, Seifalian A., Liver ischemia/reperfusion injury: Processes and inflammatory networks-A review. Liver Transplant 2010; 16: 1016-1032.
32. Hayashi PH, Axelrod DA, Galanko J, Salvalaggio PR, Schnitzler M., Regional differences in deceased donor liver transplantation and their implications for organ utilization and allocation. Clin Transplant 2011; 25: 156-163.
33. Plock J, Contaldo C, Sakai H, et al. Is hemoglobin in hemoglobin vesicles infused for isovolemichemodilution necessary to improve oxygenation in critically ischemic hamster skin ? Am J Physiol 2005; 289: H2624-H2631.
34. Patel MJ, Webb EJ, Shelbourn TE, et al. Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans. Blood 1998; 91: 710-716.
35. Abe H, Ikebuchi K, Hirayama J, et al. Virus inactivation in hemoglobin solution by heat treatment. Artif Cells Blood Substit Immobil Biotechnol 2001; 29: 381-388.
36. Sakota D, Sakamoto R, Sobajima H, et al. Mechanical damage of red blood cells by rotary blood pumps: Selective destruction of aged red blood cells and subhemolytic trauma. Artif Organs 2008; 32: 785-791.
37. Kim HW, Greenburg AG., Artificial oxygen carriers as red blood cell substitutes: A selected review and current status. Artif Organs 2004; 28: 813-828.
38. Regner KR, Nilakantan V, Ryan RP, et al. Protective effect of Lifor solution in experimental renal ischemia-reperfusion injury. J Surg Res 2010; 164: e291-e297.
39. Stowe DF, Camara AK, Heisner JS, Aldakkak M, Harder DR., Ten-hour preservation of guinea pig isolated hearts perfused at low flow with air-saturated Lifor solution at 26°C: Comparison to ViaSpan solution. Am J Physiol Heart Circ Physiol 2007; 293: H895-H901.
40. Olschewski P, Gass P, Ariyakhagorn V, et al. The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers. Cryobiology 2010; 60: 337-343.
41. Gallinat A, Fox M, Luer B, Efferz P, Paul A, Minor T., Role of pulsatility in hypothermic reconditioning of porcine kidney grafts by machine perfusion after cold storage. Transplantation 2013; 96: 538-542.
42. Vajdová K, Smreková R, Kukan M, Lutterová M, Wsõlová L., Bile analysis as a tool for assessing integrity of biliary epithelial cells after cold ischemia-reperfusion of rat livers. Cryobiology 2000; 41: 145-152.
43. Buis AI, Geuken E, Visser DS, et al. Altered bile composition after liver transplantation is associated with the development of non-anastomotic biliary strictures. J Hepatol 2009; 50: 69-79.
44. Izamis ML, Toloboom H, Uygun B, Berthiaume F, Yarmush M, Uygun K., Resuscitation of ischemic donor livers with normothermic machine perfusion: A metabolic flux analysis of treatment in rats. PLoS ONE 2013; 8: e69758.
45. Knudsen AR, Kannerup AS, Dich R, et al. Ischemic pre-and postconditioning has pronounced effects on gene expression profiles in rat livers after ischemia/reperfusion. Am J Physiol Gastrointest Liver Physiol 2012; 303: G482-G489.
46. Conti A, Scala S, D'Agostino P, et al. Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation. Liver Transplant 2007; 13: 99-113.
47. Fischer MM, Kerly M., Amino acid metabolism in the perfused rat liver. J Physiol 1964; 174: 273-294.
48. Komichi D, Tazuma S, Nishioka T, Hyogo H, Une M, Chayama K., Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. Dig Dis Sci 2003; 48: 2315-2322.
49. Paumgartner G, Beuers U., Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525-531.